Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25391,901,1.14 [1.04-1.26],0.0075630175821471
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25412,144,1.47 [1.16-1.88],0.001663083322621
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26991,155,1.28 [1.01-1.62],0.0417927754438846
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20195,494,1.44 [1.26-1.64],1.0794210875618489e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26928,92,1.43 [1.06-1.94],0.0207559886764006
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26212,76,0.94 [0.67-1.31],0.7202762304864244
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27957,91,1.41 [1.04-1.91],0.0286581680615732
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27978,64,1.09 [0.76-1.57],0.6263252404029278
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25657,45,1.81 [1.18-2.77],0.0062500798563461
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27444,107,1.06 [0.80-1.41],0.6706949967824021
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27404,67,1.01 [0.71-1.43],0.9710394606525484
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28017,66,0.98 [0.69-1.41],0.9229833719441336
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27976,98,1.28 [0.95-1.72],0.0990831410866813
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27966,88,1.38 [1.01-1.89],0.0401536558332267
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,27781,43,1.21 [0.78-1.88],0.3981169151774818
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27148,394,1.13 [0.97-1.31],0.1059160591275342
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26902,148,1.40 [1.10-1.78],0.0055783629998082
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27006,252,1.02 [0.85-1.23],0.8214641743930626
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24328,29,0.91 [0.53-1.56],0.7279963690691041
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24344,45,0.99 [0.64-1.54],0.9788412527123412
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24425,126,0.93 [0.71-1.20],0.5625482276285054
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24430,131,0.98 [0.76-1.27],0.8799957368534839
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13666,284,1.23 [1.03-1.46],0.0241869259865851
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",10944,27,0.73 [0.43-1.24],0.2449878339250587
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24348,49,1.35 [0.89-2.05],0.1640654197021304
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25897,807,1.36 [1.22-1.51],9.326355599367342e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26958,201,0.83 [0.67-1.02],0.0698689509928045
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27604,80,0.85 [0.62-1.18],0.338029218630079
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28089,72,0.87 [0.62-1.22],0.4135170750482603
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,27857,48,0.60 [0.41-0.87],0.0078454496792853
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28098,38,nan [nan-nan],
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Stomach,28137,32,0.79 [0.48-1.31],0.3681485519249587
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27830,293,1.06 [0.90-1.26],0.4715770300765275
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28068,115,1.35 [1.03-1.78],0.0280611406313868
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28072,96,1.15 [0.86-1.54],0.3563629210649083
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28036,45,1.03 [0.67-1.60],0.8843572946612468
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",28038,45,1.03 [0.67-1.60],0.8845443525107457
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,27930,241,0.89 [0.74-1.08],0.2299495056825166
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28097,106,0.90 [0.68-1.19],0.4440991206323242
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,28003,188,0.97 [0.79-1.20],0.8004528965216501
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of breast,15518,94,0.94 [0.69-1.26],0.6655877018449619
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,15159,688,1.01 [0.90-1.13],0.9138497081471808
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27120,200,1.31 [1.06-1.61],0.0112180312888086
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26999,343,1.24 [1.06-1.45],0.0072407290505175
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26999,343,1.24 [1.06-1.45],0.0072407290505175
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25782,355,1.44 [1.23-1.68],5.222164920675637e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27662,77,1.24 [0.89-1.73],0.2036343479316734
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27873,106,1.01 [0.76-1.33],0.9722432122728814
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24692,694,1.14 [1.02-1.27],0.0248728754663318
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26823,435,1.35 [1.17-1.55],3.413362615765594e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26317,111,1.96 [1.49-2.58],1.3054902152505087e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27380,54,1.17 [0.79-1.74],0.4327038595565717
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26305,99,1.92 [1.44-2.57],8.756897195613576e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26534,328,1.30 [1.10-1.53],0.0016711699303154
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26525,319,1.28 [1.09-1.51],0.0031915983335789
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26189,179,1.25 [0.99-1.58],0.0636984609169146
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26193,176,1.27 [1.00-1.61],0.0502646834315096
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24529,531,1.03 [0.91-1.18],0.6179640115387072
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24067,69,1.19 [0.84-1.69],0.3170733764454875
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24487,489,1.01 [0.88-1.16],0.8731852201449436
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24040,42,1.39 [0.89-2.17],0.1504043133677723
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24074,76,1.77 [1.27-2.46],0.0007812200472333
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,24438,765,1.20 [1.07-1.34],0.0012291080522098
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23969,296,1.15 [0.96-1.38],0.1175001118350579
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27702,228,0.98 [0.80-1.20],0.8466232739918287
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27772,163,0.92 [0.73-1.16],0.4793504126415954
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26157,83,1.10 [0.79-1.53],0.5642371308624026
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28022,83,1.08 [0.78-1.50],0.635008480476186
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23756,83,1.11 [0.80-1.55],0.5277076020421796
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Alcohol dependence,26173,99,1.03 [0.76-1.39],0.8599469830714539
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,26137,67,1.95 [1.35-2.82],0.0003935416691917
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23746,73,1.19 [0.84-1.68],0.3355347371386706
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24062,389,1.17 [1.00-1.36],0.0447153399956604
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression,26422,341,1.17 [1.00-1.37],0.0527372784257682
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,23917,300,1.11 [0.94-1.32],0.2191174125847428
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23818,145,1.22 [0.96-1.56],0.111404832948613
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,26632,68,1.12 [0.79-1.60],0.5171060459826495
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,25009,1439,1.13 [1.05-1.23],0.0022003359326765
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23334,158,1.06 [0.84-1.34],0.6181358924004714
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27932,127,1.02 [0.79-1.33],0.8554714212326079
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26779,490,1.11 [0.97-1.26],0.1333965111767888
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,26459,170,1.30 [1.04-1.63],0.0205437699362906
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,26391,102,1.26 [0.94-1.68],0.1232028044589756
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27763,93,1.22 [0.91-1.66],0.1895199878485067
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27644,41,0.84 [0.54-1.31],0.4484174319485539
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,26457,168,0.93 [0.74-1.16],0.4983207658186636
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,27518,130,0.89 [0.69-1.15],0.3838270071704756
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26995,612,1.10 [0.97-1.24],0.1248004264518335
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26517,134,0.88 [0.68-1.12],0.2998069455356901
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26715,332,1.10 [0.93-1.29],0.2640183032401256
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27915,85,1.38 [1.01-1.88],0.0442856564913704
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,27885,55,1.60 [1.09-2.34],0.016562503059048
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,27702,124,1.21 [0.93-1.57],0.161597481553774
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27663,311,1.06 [0.90-1.25],0.5060327392479821
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27521,169,1.05 [0.84-1.31],0.6570971552797984
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27441,89,0.83 [0.61-1.12],0.2278736235413364
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27455,103,0.86 [0.65-1.14],0.2956601552868808
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27402,50,1.41 [0.94-2.12],0.1009206915826952
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26414,65,1.30 [0.91-1.87],0.1529008801642914
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26535,186,1.08 [0.88-1.34],0.456563620281804
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27512,130,1.35 [1.04-1.74],0.0219318521785302
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27882,22,2.03 [1.11-3.71],0.0222119886990777
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1756,22,1.97 [1.09-3.55],0.0246707599713582
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26148,22,2.02 [1.10-3.69],0.0233679091734253
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27763,50,1.40 [0.93-2.11],0.1099253201511354
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27742,29,1.68 [0.98-2.86],0.0579194369450832
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27667,97,0.88 [0.65-1.18],0.3827256690993073
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27716,98,1.21 [0.90-1.62],0.2028258713118634
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,28008,125,0.87 [0.67-1.12],0.2785215625452797
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27605,91,1.03 [0.76-1.39],0.861055575807479
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22026,1960,1.08 [1.01-1.16],0.0284446948820361
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27815,41,1.23 [0.78-1.94],0.3682461134314901
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23082,1297,1.07 [0.99-1.17],0.1057922638206909
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,23104,1319,1.08 [0.99-1.17],0.0854786546580824
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21832,47,1.77 [1.16-2.68],0.0078232880676378
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26619,570,1.13 [1.00-1.28],0.0539869095915148
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,26402,353,1.14 [0.97-1.33],0.1059703276127505
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27421,143,1.09 [0.85-1.39],0.4894206367949822
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27545,267,1.16 [0.97-1.39],0.108580489474232
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28027,59,1.00 [0.69-1.47],0.991229263467451
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26211,162,1.24 [0.98-1.56],0.0676364868465558
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26461,423,1.13 [0.98-1.31],0.0938178020926007
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27620,81,1.21 [0.88-1.67],0.2395769780409848
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27609,176,1.33 [1.07-1.65],0.0113234802926984
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27602,63,1.49 [1.03-2.14],0.03359029160359
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27603,64,1.41 [0.98-2.03],0.0621020777709692
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21845,60,1.52 [1.05-2.21],0.0280599105185425
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25485,46,1.20 [0.78-1.84],0.4088044316444439
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,25512,73,1.58 [1.12-2.21],0.0086508433231723
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19248,95,1.08 [0.80-1.46],0.618722950685986
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19344,191,1.07 [0.87-1.33],0.5041798756056861
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25481,42,1.37 [0.88-2.15],0.1633632828463832
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25502,63,1.16 [0.81-1.67],0.4243594303823973
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27626,121,1.35 [1.04-1.76],0.0261734974126941
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27597,114,1.31 [1.00-1.72],0.047978881934607
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27629,85,1.34 [0.98-1.83],0.0676109713258093
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27677,74,1.30 [0.93-1.82],0.1222386155122905
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27403,51,1.34 [0.89-2.02],0.1643021975608288
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27435,83,1.39 [1.01-1.91],0.0457155113675254
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26895,115,1.44 [1.09-1.89],0.0089788268096915
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26874,94,1.27 [0.94-1.72],0.1200210215735157
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27969,91,1.22 [0.90-1.66],0.197102057175579
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,27216,436,1.13 [0.98-1.30],0.0903076659583468
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,27396,55,1.47 [0.99-2.17],0.0550687466250677
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23821,1951,1.15 [1.07-1.23],0.0001064217625151
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27911,135,0.81 [0.64-1.03],0.0909736335457684
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26921,189,1.32 [1.07-1.63],0.0107112317318374
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26893,161,1.31 [1.04-1.65],0.0222252188180916
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27526,216,1.44 [1.18-1.75],0.0003070710893796
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27524,214,1.46 [1.20-1.78],0.0002004941057474
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27249,669,0.94 [0.84-1.06],0.3160876129953918
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26680,100,0.87 [0.65-1.15],0.321526458774784
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,26688,108,0.94 [0.71-1.24],0.6473473450962426
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27010,430,0.92 [0.80-1.06],0.2761890182091929
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26813,233,0.87 [0.72-1.05],0.141024865228159
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16227,50,1.09 [0.71-1.65],0.7000792883977077
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25752,885,1.19 [1.08-1.32],0.0005403763754827
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,27418,109,1.45 [1.09-1.93],0.0108502196002693
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27418,109,1.45 [1.09-1.93],0.0108502196002693
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27418,109,1.45 [1.09-1.93],0.0108502196002693
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26358,804,1.15 [1.04-1.28],0.0070431366341986
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Asthma,21557,804,1.18 [1.06-1.31],0.0026440865487625
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21411,804,1.18 [1.06-1.31],0.002255223064165
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21541,788,1.16 [1.05-1.30],0.0050170938476409
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27945,56,2.57 [1.76-3.76],1.0425519326489063e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26820,43,2.84 [1.84-4.38],2.4595704286107167e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28007,43,2.79 [1.81-4.30],3.2749102228921067e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26813,36,3.15 [1.96-5.04],1.8987286339079208e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,26784,76,1.37 [0.99-1.91],0.060884887039451
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,26884,176,1.37 [1.10-1.71],0.004607078424515
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27283,80,1.42 [1.03-1.96],0.0331609060324754
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19914,5129,1.04 [0.99-1.09],0.1578855011970584
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27524,494,1.12 [0.98-1.28],0.091155289002653
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28064,138,1.03 [0.80-1.33],0.7964083989636964
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,28070,128,1.05 [0.81-1.36],0.7377591896563158
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,27153,123,0.96 [0.74-1.24],0.7544614513176805
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27136,106,1.13 [0.85-1.50],0.4070056988057169
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28050,154,1.09 [0.86-1.38],0.4889135028569128
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27126,96,1.30 [0.96-1.74],0.0890483534439539
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26868,63,1.04 [0.72-1.51],0.8169717791502841
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28014,44,0.76 [0.50-1.16],0.2073584192502328
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22648,202,1.07 [0.87-1.31],0.5439090411349652
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24182,1736,1.02 [0.94-1.09],0.6721878304516473
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,22717,271,0.76 [0.64-0.90],0.0018692575469598
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,22994,548,0.96 [0.84-1.08],0.4764008724158725
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22511,65,1.13 [0.79-1.63],0.4998994428639158
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22577,131,0.90 [0.70-1.16],0.4338258194047005
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22477,31,0.59 [0.37-0.94],0.0255496610659949
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,22546,100,1.22 [0.91-1.63],0.190632370121294
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22550,104,1.01 [0.75-1.35],0.9603353254838404
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28034,73,1.06 [0.75-1.50],0.7320882045860493
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,22549,103,1.21 [0.91-1.61],0.1989278732526297
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23077,631,0.99 [0.88-1.11],0.8310626624108096
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,27953,159,0.86 [0.68-1.08],0.1885815127042529
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,22824,378,1.09 [0.94-1.27],0.2736229587694063
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22561,115,1.19 [0.90-1.56],0.2198992949118111
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27934,190,0.84 [0.68-1.04],0.1059282698346717
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,27919,125,0.78 [0.60-1.00],0.0525957334400166
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,25356,1174,0.89 [0.82-0.97],0.0080521767059813
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,24578,396,0.82 [0.70-0.95],0.0072339178267199
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,24303,121,0.89 [0.68-1.15],0.368945662874474
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,24272,90,1.16 [0.85-1.58],0.3516466887744334
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24782,600,0.89 [0.79-1.00],0.0511888017382535
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27242,746,1.22 [1.09-1.36],0.0003381068537712
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,23165,1667,1.05 [0.97-1.13],0.2166132411662736
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27801,71,1.34 [0.94-1.90],0.1014703309193979
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28053,101,1.45 [1.09-1.95],0.0121785772933815
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,26597,101,1.47 [1.09-1.97],0.0103692596390953
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26573,77,1.43 [1.02-2.00],0.0370987372172313
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27999,131,1.32 [1.03-1.71],0.0314652879136475
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26627,131,1.33 [1.03-1.72],0.0276479306885665
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26609,113,1.42 [1.08-1.88],0.0119314225165993
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27092,596,1.22 [1.08-1.38],0.0010903744285556
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27087,591,1.21 [1.07-1.37],0.0019265693859968
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21569,71,1.48 [1.04-2.10],0.0280118580040711
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal stricture,27794,71,1.47 [1.04-2.08],0.0306350112902751
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21546,48,1.47 [0.96-2.25],0.076503698141119
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21800,302,1.03 [0.87-1.22],0.70303118169485
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21668,170,1.03 [0.82-1.29],0.7952828672406437
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21750,252,1.25 [1.04-1.51],0.0162535100241271
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,26952,226,1.32 [1.09-1.61],0.0049143809502485
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27713,82,1.69 [1.22-2.33],0.001488689300807
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21677,179,0.83 [0.67-1.03],0.0936910811084942
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21585,87,0.82 [0.60-1.12],0.2098985456258859
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22289,791,1.03 [0.93-1.15],0.5265532202703375
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,21678,180,1.14 [0.91-1.41],0.2514339563772109
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27700,69,1.70 [1.20-2.42],0.0031273403371425
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,27397,125,1.33 [1.03-1.73],0.0302203283753882
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,27338,66,1.28 [0.89-1.83],0.182764726915423
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26893,528,1.17 [1.03-1.34],0.0137394725697074
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,26778,413,1.09 [0.94-1.26],0.2459756742316378
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,26443,78,1.09 [0.78-1.52],0.6067263729486643
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26412,47,1.14 [0.75-1.75],0.5350174528394283
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,26427,62,1.13 [0.78-1.64],0.5213174187465446
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27965,62,1.12 [0.78-1.63],0.5376485403133592
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26858,281,1.28 [1.07-1.52],0.0062799884468977
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26642,65,1.90 [1.32-2.73],0.0005903541054208
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,26628,51,2.12 [1.41-3.19],0.0003325086252347
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26619,42,1.44 [0.91-2.27],0.1163327727064398
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26758,181,1.08 [0.87-1.34],0.4966715395263252
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,26753,176,1.06 [0.85-1.32],0.6003932578674283
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25526,1480,1.02 [0.94-1.10],0.6599371966129879
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27748,102,1.02 [0.77-1.36],0.8881008360922754
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27694,459,0.94 [0.82-1.08],0.3726167386134926
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27029,532,1.08 [0.95-1.23],0.2411112313196108
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27352,394,1.09 [0.94-1.26],0.2641959382305048
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27065,107,1.02 [0.77-1.35],0.8997180472340363
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27181,223,1.08 [0.89-1.31],0.4612260914577607
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27881,86,0.95 [0.69-1.29],0.7341061880224231
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27868,73,0.93 [0.66-1.30],0.6728410316108548
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27847,52,0.91 [0.61-1.35],0.6314348735988995
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27962,34,0.91 [0.55-1.50],0.7200022780898023
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27959,31,0.93 [0.55-1.57],0.7799897870453012
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27297,62,1.09 [0.75-1.58],0.643210027121718
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27588,353,0.93 [0.79-1.08],0.3285019804071424
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26569,72,1.02 [0.72-1.44],0.90290055598302
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26596,99,1.16 [0.87-1.56],0.3151448259766399
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26580,83,1.09 [0.79-1.51],0.5946905241107008
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26708,211,1.03 [0.84-1.26],0.7751882872878798
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26679,182,1.03 [0.83-1.28],0.7644599427121946
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21780,3512,1.12 [1.06-1.18],3.249663073270077e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23410,1858,1.10 [1.02-1.18],0.0086245376695447
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25685,1101,1.07 [0.97-1.17],0.1673148448150043
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21670,118,1.33 [1.02-1.74],0.0364228008533965
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21892,340,1.25 [1.06-1.46],0.0065966699325442
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27802,112,1.30 [0.99-1.71],0.0602274810897749
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27819,100,1.39 [1.04-1.86],0.0253445157499086
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22208,656,1.01 [0.90-1.14],0.845011310698053
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24798,656,1.01 [0.90-1.14],0.8415546526959313
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21595,43,0.60 [0.40-0.90],0.0138494145494882
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27743,42,0.59 [0.40-0.88],0.0088816866485289
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21706,154,1.33 [1.05-1.69],0.0168874569947624
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21577,25,0.83 [0.47-1.47],0.5233306892440852
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21676,124,0.98 [0.75-1.27],0.851224791057941
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28020,62,0.81 [0.56-1.16],0.2488032828932753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,21877,325,0.97 [0.82-1.14],0.6757059232473809
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21775,223,1.13 [0.92-1.37],0.2380405124516703
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22789,1237,1.08 [1.00-1.18],0.0622497990930772
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21590,38,2.34 [1.46-3.75],0.0003856559663716
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21724,172,1.26 [1.01-1.58],0.0419122434497142
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21588,36,0.94 [0.58-1.53],0.8025845956346429
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21582,30,1.80 [1.05-3.10],0.0333697732433554
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22076,524,0.97 [0.85-1.10],0.6157477253555396
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21987,435,1.01 [0.88-1.16],0.9038814834110211
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22286,277,1.13 [0.95-1.35],0.1569862375481359
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27744,151,2.07 [1.64-2.60],8.408178345286581e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27633,40,2.51 [1.61-3.93],5.484593863466916e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25170,48,0.99 [0.65-1.51],0.9694853886492152
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25339,217,1.10 [0.90-1.33],0.36599763711437
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26019,897,1.13 [1.02-1.25],0.0163869436774091
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25256,134,0.99 [0.77-1.28],0.9658059366799656
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25178,56,1.25 [0.85-1.84],0.2565183799857159
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25875,753,1.13 [1.01-1.26],0.0260005099059537
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25179,57,1.33 [0.90-1.96],0.1491722250035329
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25370,248,1.01 [0.84-1.21],0.9236885326201888
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25234,112,1.10 [0.83-1.45],0.5024245955926698
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25192,70,1.01 [0.71-1.42],0.9620063652127532
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25269,147,1.30 [1.02-1.65],0.0340095310806856
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25187,65,1.16 [0.81-1.67],0.4040163068586034
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25441,319,1.08 [0.92-1.27],0.3682650176882435
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24869,285,0.96 [0.81-1.14],0.6375692684080919
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24640,56,0.97 [0.65-1.43],0.8674543262829258
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24639,55,1.27 [0.86-1.88],0.2354952346463653
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24698,114,0.91 [0.69-1.19],0.4835637908670586
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24642,58,0.84 [0.57-1.22],0.3516137425908097
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24647,63,0.75 [0.52-1.07],0.1148355608518186
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24632,48,0.54 [0.38-0.79],0.0012141397376847
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24812,228,1.10 [0.90-1.33],0.3460853539880574
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24634,50,0.93 [0.62-1.40],0.7391174117412422
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24639,55,1.03 [0.69-1.53],0.8842850137917428
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24697,113,1.09 [0.83-1.43],0.5503717508655133
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24654,70,1.19 [0.84-1.69],0.325914917306094
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25008,424,1.29 [1.12-1.49],0.0004351580841554
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24723,139,1.33 [1.04-1.70],0.0253703109411619
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24807,223,1.28 [1.05-1.55],0.0146112540893328
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26747,99,1.31 [0.98-1.76],0.0695203735474733
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26988,340,1.23 [1.05-1.44],0.0119277309382469
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26704,56,1.03 [0.70-1.53],0.8695594852103341
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26717,69,1.04 [0.73-1.48],0.8171315692471564
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26763,115,1.04 [0.79-1.36],0.7800213041276837
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23786,4397,1.15 [1.10-1.21],1.3236188562790886e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11415,410,1.07 [0.92-1.24],0.3934322479057278
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26594,208,1.57 [1.28-1.92],1.447242334781527e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26440,54,1.33 [0.89-1.99],0.1606985103617701
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26752,44,2.27 [1.48-3.50],0.0001942256435187
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26756,48,1.91 [1.26-2.89],0.0024561653976398
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26761,53,1.92 [1.28-2.86],0.0014521871809711
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27756,239,1.03 [0.85-1.24],0.7948190581424952
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27832,52,2.07 [1.39-3.09],0.0003422497431576
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27684,167,0.94 [0.75-1.18],0.6081742846049425
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27612,95,0.90 [0.67-1.20],0.4604612418331096
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26609,886,1.08 [0.97-1.19],0.1472905964897571
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,25806,83,1.09 [0.79-1.51],0.5918872716409723
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25788,65,1.04 [0.72-1.49],0.8473341269212118
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25905,182,0.98 [0.79-1.22],0.8584632011866571
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25810,87,1.19 [0.87-1.63],0.2637452848769591
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26348,625,1.09 [0.97-1.22],0.1619568017721165
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11075,70,1.21 [0.84-1.74],0.298230229838048
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11040,35,1.41 [0.85-2.35],0.1845241128766505
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,11043,38,0.90 [0.56-1.45],0.6680795963094776
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11094,89,0.94 [0.69-1.27],0.6727240695368362
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11071,66,0.93 [0.64-1.34],0.6844723011684747
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11109,104,1.37 [1.02-1.84],0.0346291883631925
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15368,247,0.95 [0.78-1.14],0.5568913300531622
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15191,70,1.03 [0.72-1.46],0.8807789705557223
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15208,87,1.02 [0.74-1.40],0.9079469793416676
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15176,55,0.89 [0.60-1.32],0.5616994827940103
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15332,394,0.87 [0.75-1.00],0.0542308311861663
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,15022,84,0.75 [0.55-1.02],0.0665315722191729
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15130,192,0.88 [0.71-1.08],0.2243488968061796
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14136,2769,0.93 [0.88-0.99],0.0283903689793891
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11664,297,0.89 [0.75-1.06],0.1961253598902683
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11457,90,1.14 [0.84-1.56],0.40344789430444
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11483,116,0.74 [0.57-0.97],0.0266561273684644
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11676,309,0.75 [0.63-0.88],0.0004928030642041
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11667,300,0.87 [0.73-1.03],0.1092514227625952
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11847,480,1.09 [0.95-1.25],0.220610300256107
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11534,167,1.17 [0.93-1.48],0.1749899141538387
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11583,216,0.96 [0.79-1.17],0.6909948851003147
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11449,82,1.05 [0.76-1.47],0.7510254578768384
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11508,141,0.79 [0.62-1.01],0.0558418016383237
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15520,202,0.80 [0.65-0.98],0.0308836326602071
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15530,194,0.79 [0.65-0.97],0.0271181407782344
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15550,111,0.80 [0.61-1.05],0.1102624991528771
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15541,120,0.82 [0.63-1.06],0.1296433465930796
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11441,74,0.96 [0.68-1.34],0.8031833599434103
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11429,62,0.91 [0.63-1.32],0.622055425777071
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11443,76,0.99 [0.71-1.39],0.9547755556979048
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15444,379,0.92 [0.80-1.08],0.3086291767187354
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12506,1139,0.96 [0.87-1.05],0.3466644204557467
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12144,777,0.96 [0.86-1.07],0.4515991205307805
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15529,157,0.90 [0.71-1.13],0.3618625291109479
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11722,355,0.86 [0.73-1.00],0.056761593901512
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11642,275,1.05 [0.88-1.25],0.6088797352474766
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11627,260,0.87 [0.72-1.05],0.1507576417517371
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female infertility,11483,116,0.94 [0.71-1.24],0.6502330892102908
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11476,109,0.93 [0.70-1.24],0.6363400891029194
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15543,878,0.96 [0.86-1.07],0.4581370146186551
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15550,1197,0.97 [0.88-1.07],0.5942170481128144
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15546,475,0.88 [0.77-1.01],0.0773864698327381
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15208,137,0.87 [0.67-1.12],0.2668944312691573
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15260,189,0.74 [0.60-0.91],0.0046554073279402
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15233,162,1.07 [0.85-1.35],0.564914650113007
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15563,162,1.08 [0.85-1.36],0.5280575572786337
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15565,159,1.07 [0.85-1.36],0.5494214492599125
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15561,420,1.01 [0.87-1.17],0.940847716384854
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15268,127,1.06 [0.82-1.38],0.6584936257747476
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15372,231,0.99 [0.82-1.21],0.9562770652371656
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14812,147,1.07 [0.83-1.37],0.6172269778444741
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14867,202,0.91 [0.74-1.12],0.3743022027270889
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,14917,252,1.06 [0.88-1.28],0.5393326633931568
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14812,147,0.85 [0.66-1.09],0.1942512366879464
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14803,138,0.92 [0.72-1.19],0.5386625989225324
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14814,149,0.92 [0.72-1.17],0.4854451654399869
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14583,230,0.93 [0.76-1.14],0.5016951897702986
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14790,437,1.03 [0.89-1.20],0.6648552194059749
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15022,669,1.00 [0.88-1.13],0.9393640342059704
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15567,169,0.93 [0.74-1.18],0.5604332323402943
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,14109,128,0.95 [0.73-1.23],0.7049704224779137
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14456,103,1.13 [0.84-1.52],0.4316761718241899
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15574,340,0.89 [0.76-1.05],0.1750867546721105
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15494,260,0.82 [0.68-0.99],0.038385814762737
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15561,253,1.02 [0.85-1.24],0.8125590654738689
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15551,243,1.04 [0.86-1.26],0.6846291685922894
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27885,36,1.23 [0.76-1.99],0.4030380724895752
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26471,529,0.99 [0.87-1.12],0.8389398636169662
